Inhibiting HMGB1 in irradiated MB49 tumors significantly impairs infiltration of myeloid derived suppressor cells (MDSC) and tumor associated macrophages (TAMs) in the TIME, and shifts the overall tumor immune balance towards an anti-tumoral response. The gene discussed is HMGB1; the disease is neoplasm.